KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Accumulated Expenses (2016 - 2025)

Amgen (AMGN) has 17 years of Accumulated Expenses data on record, last reported at $18.5 billion in Q4 2025.

  • For Q4 2025, Accumulated Expenses rose 5.0% year-over-year to $18.5 billion; the TTM value through Dec 2025 reached $18.5 billion, up 5.0%, while the annual FY2025 figure was $18.5 billion, 5.0% up from the prior year.
  • Accumulated Expenses reached $18.5 billion in Q4 2025 per AMGN's latest filing, up from $16.8 billion in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $18.5 billion in Q4 2025 and bottomed at $9.0 billion in Q2 2021.
  • Average Accumulated Expenses over 5 years is $13.4 billion, with a median of $13.7 billion recorded in 2023.
  • Peak YoY movement for Accumulated Expenses: dropped 3.21% in 2021, then surged 30.09% in 2023.
  • A 5-year view of Accumulated Expenses shows it stood at $10.7 billion in 2021, then grew by 16.71% to $12.5 billion in 2022, then grew by 22.64% to $15.4 billion in 2023, then grew by 14.86% to $17.6 billion in 2024, then grew by 5.0% to $18.5 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Accumulated Expenses were $18.5 billion in Q4 2025, $16.8 billion in Q3 2025, and $15.0 billion in Q2 2025.